iToBoS XAI Workshop

The iToBoS consortium conducted an explainable AI (xAI) workshop at the project’s 6th General Assembly meeting, hosted by Bosch Manufacturing Solutions facility, in Madrid in October 2023.

Solutions for the data economy of tomorrow-creating a secure, trusted environment for handling medical data

Bilbao hosted the technology-focused Tech-X Conference of the Gaia-X initiative, which was co-organized with a Hackathon.

Intelligent total body scanner featured in a documentary on TV

Intelligent Total Body Scanner was presented as a use case for artificial intelligent in medicine in TV program.

iToBoS 5th Newsletter launched

The fifth issue of the iToBoS newsletter was released!

Influential policy makers in NTUA European Researchers' Night

During the NTUA European Researchers' Night, co-organized by the National Technical University of Athens (NTUA) and the Technical Chamber of Greece, influential policy makers attended the event.

Spotting the difference: how do you tell melanomas apart from healthy moles?

The earlier you find a skin cancer, the easier and more effective the treatment is. However, it’s not always easy to tell apart harmless, healthy moles and those that need excision and histopathology analysis.

Policymakers and businesspeople visited the iToBoS prototype

During the Bosch Innovation Day held on September 23, 2023, the iToBoS project played a central role at Bosch Madrid.

Anonymization and annotation data flow in the University of Queensland

The data obtained in the University of Queensland (UQ) will follow a specific data flow that will differ slightly on the one followed by the Clínic Hospital in Barcelona.

Assessing UV Damage to the Skin with AI Image Recognition: What You Need to Know

Exposure to sun ultraviolet (UV) radiation can cause significant damage to the skin, leading to premature aging, sunburn, and an increased risk of skin cancer.

Anonymization and annotation data flow in Hospital Clínic Barcelona

In the iToBoS project we will follow two slightly different data flows depending on the point of origin of the patient’s data, due to differences between data protection regulation in Europe vs. Australia.